SEATTLE, Nov. 28 /PRNewswire-FirstCall/ -- On Monday, December 1, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the agreement with Spectrum Pharmaceuticals of Irvine, California to jointly market and develop Zevalin(R).
Conference Call Numbers Monday, December 1 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-800-219-6110 (US Participants) 1-303-262-2053 (International) Call-back numbers for post-listening available at 11:30 a.m. Eastern: 1-800-405-2236 (US Participants) 1-303-590-3000 (International) Passcode: 11123066#
Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends
Slides for the webcast can be accessed at: http://www.celltherapeutics.com/investor_updates Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 F: 206.272.4434 E: firstname.lastname@example.org www.celltherapeutics.com/press_room Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch Logan T: 206.272.4347 F: 206.272.4434 E: email@example.com www.celltherapeutics.com/investors
|SOURCE Cell Therapeutics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved